BriaCell Pivotal Phase 3 Clinical Trial Site at Sunnybrook's Odette Cancer Centre
Sector: Healthcare • Location: Toronto, Ontario, Canada
Source: Investing News Network
Sunnybrook's Odette Cancer Centre in Toronto, Ontario, Canada, has joined BriaCell's pivotal Phase 3 clinical trial evaluating Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. This expands access to the trial for Canadian patients as part of BriaCell's ongoing study.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | under construction |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Sunnybrook's Odette Cancer Centre in Toronto, Ontario, Canada, has joined BriaCell's pivotal Phase 3 clinical trial evaluating Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. This expands access to the trial for Canadian patients as part of BriaCell's ongoing study. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |